Project Grant HT9425261E226
Award Date 7/1/26
Completion Date 6/30/28
Dollars Obligated $560K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
- The Department of Defense's Defense Health Agency has awarded a $1,258,719 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant, awarded on July 15, 2024, will support a 3-year research project titled "Melanoma Chemoprevention via Neuropilin-2 Axis Blockade." Through this grant, Boston Children's Hospital will conduct biomedical research focused on...
- The Defense Health Agency awarded a $3,062,579 Project Grant to The Children's Hospital Corporation, doing business as Boston Children's Hospital, for the period of April 15, 2025 to April 14, 2029. The grant is funded under the Military Medical Research and Development program (CFDA 12.420) to support an integrated approach toward identifying biopsychosocial aspects of pain in fibrous dysplasia/McCune-Albright syndrome. As a leading pediatric medical research institution, Boston Children's...
- FEDERAL GRANT AWARD SUMMARY The Defense Health Agency (DHA) awarded President and Fellows of Harvard College, operating through Harvard Medical School, a $1.352 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award supports research focused on targeted therapy development through spatial molecular profiling for rare pediatric and adult brain tumors using limited tissue samples. This research...
- The federal Project Grant award in the amount of $617,367 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is being used by the Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on "BASE EDITING TO IMPROVE CONDITIONING AND TRANSPLANT OF BONE MARROW FAILURE PATIENTS". The research project aims to leverage innovative gene editing techniques to enhance the...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $934,501 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research focused on developing peptide-centric chimeric antigen receptor (CAR) T-cell therapies for neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors...
- Federal Project Grant Award Summary Boston University Medical Campus received a $6.52 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Brief Caspase Inhibition for Neuroprotection in Pediatric Cardiac Surgery," with an award date of August 1, 2025, and a performance period extending through July 31, 2029. This four-year research initiative will be conducted at the awardee's facility...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $712,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, with completion targeted for August 31, 2027. The award funds the development of a GPC2 CAR T cell-amplifying extracellular vesicle vaccine, representing a translational immunotherapy research initiative aimed at advancing cancer...
- The U.S. Department of the Army Medical Command has awarded a $577,383.00 Project Grant to The Children's Hospital Corporation, doing business as Boston Children's Hospital, under the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant, with a performance period from September 1, 2024 to August 31, 2027, will support the hospital's research to develop base editing techniques to improve conditioning and transplantation of bone marrow failure patients. As a...
- Federal Grant Award Summary Children's Research Institute received a $777,659 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2028. The award supports research titled "Use of ProResolution and Restorative Pharmacology Approaches for DMD Therapy," focusing on the development of innovative therapeutic interventions for Duchenne muscular dystrophy (DMD). The...
- Federal Project Grant Award Summary Dana-Farber Cancer Institute, Inc. (DFCI) received a $1.1 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a four-year period from June 1, 2026, through May 31, 2030. The award funds research and development activities focused on the project titled "LISTEN: Augmenting and Facilitating Communication in Brain Tumor Patients with Aphasia," which addresses...